Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ellis J Neufeld, MD, PhD
Boston Children's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla, Mattel Children'S Hospital
Los Angeles, California, United States
- Stanford University School of Medicine
Palo Alto, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Emory University School of Medicine
Atlanta, Georgia, United States
- Children'S Hospital Boston
Boston, Massachusetts, United States
- Van Eslander Cancer Center, St. John Hospital
Detroit, Michigan, United States
- Weill Medical College at Cornell University
New York, New York, United States
- Southwestern Medical Center at Dallas
Dallas, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2003
- Primary completion
- 31 Dec 2005
- Completion
- 31 Dec 2005
- Last update posted
- 9 Nov 2012
- Registered enrollment
- 36
- Registry id
- NCT01713738
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.